DEVELOPMENT OF LEUKEMIA AFTER COVID-19 INFECTION
DOI:
https://doi.org/10.30888/2663-5712.2022-15-01-011Keywords:
COVID-19, leukemia, clinical case.Abstract
Many aspects of the COVID-19 infection, especially its complications and long-term health consequences, are still unknown. Various reactive changes in the blood test during the course of leukemia have been published. Leukocytosis [1], leukopenia [2, 3, 4]Metrics
References
Lippi G, Plebani M. The critical role of laboratory medicine during
coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab
Med. 2020.
Guan W. et al., ‘Clinical Characteristics of Coronavirus Disease 2019 in
China’, N. Engl. J. Med., vol. 382, no. 18, pp. 1708–1720, Apr. 2020.
Wu C. et al., ‘Risk Factors Associated With Acute Respiratory Distress
Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in
Wuhan, China’, JAMA Intern. Med., Mar. 2020.
Wang D. et al., ‘Clinical Characteristics of 138 Hospitalized Patients With
Novel Coronavirus-Infected Pneumonia in Wuhan, China.’, JAMA, vol. 323, no. 11, p. 1061, Feb. 2020.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics
of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive
study. Lancet. 2020 Feb 15;395(10223):507-513.
Qian GQ, Yang NB, Ding F, et al. Epidemiologic and Clinical
Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A
retrospective, multi-centre case series. QJM. 2020 Mar 17. pii: hcaa089.
Costa B.A., Luz C.V., Campos S.E.V., Lopez G.S., Leitao J.P.V., Duarte F.B. Can SARS-CoV-2 cause hematologic malignancies in susceptible individuals? Case series and literature review. Hematol Transfus Cell Ther. 2022;44:26-31.
Nekooghadam S.M., Moradi A., Toudeshki K. K.and Pishgahi M. A Case of Acute Leukemia Following Remission of COVID-19 Infection; an Urge to Search for a Probable Association. Arch Acad Emerg Med. 2021; 9(1): e51.
Lanza K., Perez L.G., Costa L.B. et al. Covid-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (Lond), 134 (2020), pp. 1259-1264
Haznedaroglu I.C., Malkan U.Y. Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies. Eur Rev Med Pharmacol Sci, 20 (2016), pp. 4089-4111 Medline
Gupta A., Madhavan M.V., Sehgal K. et al. Extrapulmonary manifestations of COVID-19.Nat Med, 26 (2020), pp. 1017-1032 http://dx.doi.org/10.1038/s41591-020-0968-3 | Medline
Shang J., Ye G., Shi K. et al. Structural basis of receptor recognition by SARS-CoV-2.Nature, (2020), pp. 1-8 http://dx.doi.org/10.1038/s41586- 020-2179-y
Rivellese F., Prediletto E. ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia.Autoimmun Rev, 19 (2020),
Cheng H., Wang Y., Wang G-Q. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J. Med Virol, (2020), pp. 0-3 http://dx.doi.org/10.1002/jmv.25785
Haznedaroglu I.C., Beyazit Y. Pathobiological aspects of the local bone marrow renin-angiotensin system: a review.J Renin Angiotensin Aldosterone Syst, 11 (2010), pp. 205-213 http://dx.doi.org/10.1177/1470320310379876 | Medline
Beyazit Y., Aksu S., Haznedaroglu I.C. et al. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J. Natl Med Assoc, 99 (2007), pp. 57-63 Medline
De la Iglesia Iñigo S., López-Jorge C.E., Gómez-Casares M.T. et al. Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents. Leuk Res, 33 (2009), pp. 810-816 http://dx.doi.org/10.1016/j.leukres.2008.09.029 | Medline
Kozako T., Soeda S., Yoshimitsu M. et al. Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells. FEBS Open Bio, 13:6 (2016), pp. 442-460 http://dx.doi.org/10.1002/2211-5463.13351 | Medline
Saini G., Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays, 43 (2021), http://dx.doi.org/10.1002/bies.202100048 | Medline
Han H.J., Nwagwu C., Anyim O., Ekweremadu C., Kim S. COVID-19 and cancer: from basic mechanisms to vaccine development using nanotechnology. Int. Immunopharmacol, 90 (2021)
Ma-Lauer Y., Carbajo-Lozoya J., Hein M.Y. et al. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A, 113 (2016), pp. E5192-E5201. http://dx.doi.org/10.1073/pnas.1603435113 | Medline
Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer, 18 (2018), pp. 471-484. http://dx.doi.org/10.1038/s41568-018-0015-6 | Medline
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
